References
- d'Aloja E, Paribello F, Demontis R, Muller M. Off-label drugs prescription in neonatology: a physician's duty or a medical hazardous attitude? J Matern Fetal Neonatal Med 2011;24:99–100
- Nguyen KA, Claris O, Kassai B. Unlicensed and off-label drug use in a neonatal unit in France. Acta Paediatr 2011;100:615–17
- Guideline on pharmaceutical development of medicines for paediatric use. 2013. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2013/07/WC500147002.pdf [last accessed 17 May 2014]
- Jacqz-Aigrain E. Drug policy in Europe Research and funding in neonates: current challenges, future perspectives, new opportunities. Early Hum Dev 2011;87:S27–30
- Fabiano V, Mameli C, Zuccotti GV. Paediatric pharmacology: remember the excipients. Pharmacol Res 2011;63:362–5
- Lass J, Naelapaa K, Shah U, et al. Hospitalised neonates in Estonia commonly receive potentially harmful excipients. BMC Pediatr 2012;12:136
- American Academy of Pediatrics Committee on Drugs. “Inactive” ingredients in pharmaceutical products: update (subject review). Pediatrics 1997;99:268–78
- European commission. Guidelines. Medicinal products for human use. Safety, environment and information. Excipients in the label and package leaflet of medicinal products for human use. 2003. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003412.pdf [last accessed 17 May 2014]
- EMA Committee for medicinal products for human use (CHMP). Guideline on excipients in the dossier for application for marketing authorisation of a medicinal product. 2007. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003382.pdf [last accessed 17 May 2014]
- Turner MA, Duncan JC, Shah U, et al. Risk assessment of neonatal excipient exposure: lessons from food safety and other areas. Adv Drug Deliv Rev 2014;73C:89–101
- Lexi-Comp On-Line. Available from: http://online.lexi.com [last accessed 17 May 2014]
- Rowe RC, Sheskey PJ, Quinn ME. Handbook of pharmaceutical excipients. 6th ed. London, UK: Pharmaceutical Press; 2009
- Council of Europe. European Pharmacopoeia, 8th ed. Strasbourg: EDQM; 2013
- Formularium Slovenicum 3.0 JAZMP. Ljubljana: Present d.o.o.; 2011
- Costello I, Long PF, Wong IK, et al. Paediatric drug handling. London, UK: Pharmaceutical Press; 2007
- EMA Committee for medicinal products for human use (CHMP). Reflection paper: formulations of choice for the Paediatric population. 2006. Available from: http://www.ema.europa.eu/docs/en_GB/document_library/Scientific_guideline/2009/09/WC500003782.pdf [accessed 17 May 2014]
- Jamnik K. Implementation of the decree on drugs for paediatric use in slovene health system. Ljubljana; University of Ljubljana, Faculty of Pharmacy; 2008
- Dotta A, Braguglia A, Salvatori G. Pharmacological research in neonatology. J Matern Fetal Neonatal Med 2011;24:44–6
- Dell'Aera M, Gasbarro AR, Padovano M, et al. Unlicensed and off-label use of medicines at a neonatology clinic in Italy. Pharm World Sci 2007;29:361–7
- ‘t Jong GW, van der Linden PD, Bakker EM, et al. Unlicensed and off-label drug use in a paediatric ward of a general hospital in the Netherlands. Eur J Clin Pharmacol 2002;58:293–7
- ‘t Jong GW, Vulto AG, de Hoog M, et al. Unapproved and off-label use of drugs in a children's hospital. N Engl J Med 2000;343:1125
- Whittaker A, Currie AE, Turner MA, et al. Toxic additives in medication for preterm infants. Arch Dis Child Fetal Neonatal Ed 2009;94:F236–40
- Nahata MC. Safety of “inert” additives or excipients in paediatric medicines. Arch Dis Child Fetal Neonatal Ed 2009;94:F392–3
- Svirskis D, Toh M, Ram S. The use of ethanol in paediatric formulations in New Zealand. Eur J Pediatr 2013;172:919–26
- Kimland E, Odlind V. Off-label drug use in pediatric patients. Clin Pharmacol Ther 2012;91:796–801